{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:54:54Z","timestamp":1791258894628,"version":"4.1.0"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>High mobility group box chromosomal protein 1 (HMGB1) has been implicated as a mediator of inflammation in rheumatoid arthritis (RA), while its role in juvenile idiopathic arthritis (JIA) has not been described. To evaluate the role of HMGB1 in the inflammatory process in JIA and its potential as a therapeutic target, we investigated whether extracellular HMGB1 is detectable in JIA and if so, to correlate the levels with established inflammatory markers and clinical measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Matching samples of blood and synovial fluid (SF) were collected from 23 patients with JIA. Levels of HMGB1, soluble receptor for advanced glycation endproducts, S100A12, myeloid-related protein 8\/14, and other inflammatory mediators were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Significantly increased HMGB1 levels were recorded in SF compared to blood samples from patients with JIA. The amount of HMGB1 was highest in patients with early disease onset irrespective of disease duration. In contrast, the proinflammatory S100 protein and interleukin 8 were highest in patients in early phases of disease. Matrix metalloproteinase-3, a marker of cartilage destruction, was higher in patients with late disease onset, indicating similarities with RA in that patient subgroup.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Levels of extracellular HMGB1 are increased in the inflamed joints of patients with JIA. This warrants further studies of HMGB1 as a mediator of JIA pathogenesis as well as a biomarker for inflammatory activity and as a target for therapy. The variation in levels of HMGB1 and S100 proteins in relation to disease onset indicates a difference in inflammatory phenotype during disease progression.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.120987","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T04:53:47Z","timestamp":1373950427000},"page":"1604-1613","source":"Crossref","is-referenced-by-count":49,"title":["HMGB1 Levels Are Increased in Patients with Juvenile Idiopathic Arthritis, Correlate with Early Onset of Disease, and Are Independent of Disease Duration"],"prefix":"10.3899","volume":"40","author":[{"given":"Hanna","family":"Schierbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rille","family":"Pullerits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Pruunsild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Holzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Laestadius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Erlandsson","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2013,7,15]]},"reference":[{"key":"2018112909315649000_40.9.1604.1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909315649000_40.9.1604.2","first-page":"1520","article-title":"Worldwide prevalence of juvenile arthritis \u2014 Why does it vary so much?","volume":"29","author":"Manners","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909315649000_40.9.1604.3","first-page":"579","article-title":"Remission in juvenile chronic arthritis: A cohort study of 683 consecutive cases with a mean 10 year followup","volume":"30","author":"Fantini","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909315649000_40.9.1604.4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003893107"},{"key":"2018112909315649000_40.9.1604.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000010"},{"key":"2018112909315649000_40.9.1604.6","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00389"},{"key":"2018112909315649000_40.9.1604.7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120189"},{"key":"2018112909315649000_40.9.1604.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2012.10.037"},{"key":"2018112909315649000_40.9.1604.9","doi-asserted-by":"publisher","DOI":"10.1186\/ar3450"},{"key":"2018112909315649000_40.9.1604.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.23729"},{"key":"2018112909315649000_40.9.1604.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.11028"},{"key":"2018112909315649000_40.9.1604.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.11161"},{"key":"2018112909315649000_40.9.1604.13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2119\/molmed.2010.00264","article-title":"Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models","volume":"17","author":"Schierbeck","year":"2011","journal-title":"Mol Med"},{"key":"2018112909315649000_40.9.1604.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.27590"},{"key":"2018112909315649000_40.9.1604.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.02.023"},{"key":"2018112909315649000_40.9.1604.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.12.019"},{"key":"2018112909315649000_40.9.1604.17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.43.25752"},{"key":"2018112909315649000_40.9.1604.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110058"},{"key":"2018112909315649000_40.9.1604.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.20125"},{"key":"2018112909315649000_40.9.1604.20","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X"},{"key":"2018112909315649000_40.9.1604.21","doi-asserted-by":"publisher","DOI":"10.1042\/bj3010655"},{"key":"2018112909315649000_40.9.1604.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.07.004"},{"key":"2018112909315649000_40.9.1604.23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei025"},{"key":"2018112909315649000_40.9.1604.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.10859"},{"key":"2018112909315649000_40.9.1604.25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep125"},{"key":"2018112909315649000_40.9.1604.26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01299.x"},{"key":"2018112909315649000_40.9.1604.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.23516"},{"key":"2018112909315649000_40.9.1604.28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080782"},{"key":"2018112909315649000_40.9.1604.29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4240"},{"key":"2018112909315649000_40.9.1604.30","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfp235"},{"key":"2018112909315649000_40.9.1604.31","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P"},{"key":"2018112909315649000_40.9.1604.32","first-page":"826","article-title":"Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides","volume":"29","author":"Gattorno","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909315649000_40.9.1604.33","first-page":"386","article-title":"Prognostic factors in juvenile rheumatoid arthritis: A case-control study revealing early predictors and outcome after 14.9 years","volume":"30","author":"Flato","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909315649000_40.9.1604.34","doi-asserted-by":"publisher","DOI":"10.1002\/art.27657"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.120987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:28:16Z","timestamp":1543516096000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.120987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,15]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,1]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.3899\/jrheum.120987"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.120987","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,15]]}}}